WHO ICTRP trial
Sotorasib and Panitumumab Versus Investigator's Choice for Participants With…
JPRN-jRCT2011210078 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2011210078 |
|---|---|
| Public title | Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation |
| Scientific title | A Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib and Panitumumab Versus Investigator's Choice (Trifluridine and Tipiracil, or Regorafenib) for the Treatment of Previously Treated Metastatic Colorectal Cancer Subjects With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation |
| Primary sponsor | Nakatani Iwam |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | United States;Japan;Australia;Japan;France;Japan;Germany;Japan;Greece;Japan;Italy;Japan;Korea;Japan;Spain;Japan |
| Conditions | Colorectal Cancer (CRC) |
| Interventions | Experimental: Arm A: Sotorasib 960 mg once daily (QD) + panitumumab Interventions: Drug: Sotorasib Drug: Panitumumab Experimental: Arm B: Sotorasib 240 mg QD + panitumumab Interventions: Drug: Sotorasib Drug: Panitumumab Active Comparator… |
| Registration date | Mar 26, 2022 |
| Target size | 153 |
| Secondary IDs | NCT05198934 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: